Hana Health by DSS Imagetech Partners with Overture Life to Bring World-First Automated Egg-Freezing Technology to India

Why It Matters

Automating egg freezing removes a major bottleneck, boosting IVF success rates while lowering costs for clinics and patients. This shift could reshape India’s fertility market by making high‑quality reproductive care scalable and affordable.

Key Takeaways

• First automated egg‑freezing system in India
• Standardizes vitrification, reducing variability and cycle failures
• Increases clinic throughput without extra staff
• Lowers infrastructure cost, enabling smaller labs
• Backed by US, UK, EU regulatory clearances

Pulse Analysis

India’s fertility sector is confronting unprecedented demand, driven by delayed family planning and rising awareness of assisted reproductive technologies. Traditional manual vitrification processes are labor‑intensive and prone to subtle variations that can jeopardise embryo viability, creating a capacity crunch in both metropolitan and regional clinics. By introducing automation, the market addresses a critical scalability issue, allowing providers to serve a broader patient base without compromising clinical rigor.

DaVitri leverages microfluidic engineering to execute vitrification under tightly controlled, data‑driven protocols. The platform delivers consistent cooling rates, eliminates human error, and accelerates throughput, enabling laboratories to process dozens more cycles per day with the same staffing levels. Cost‑wise, the system reduces capital outlay from multi‑million‑dollar cryostorage setups to a fraction, opening doors for smaller clinics and satellite centres to offer premium egg‑freezing services previously reserved for large academic hubs.

For Hana Health, the exclusive partnership with Overture Life positions the company at the forefront of India’s IVF modernization, complementing its broader life‑science portfolio. Overture gains a foothold in a high‑growth market, backed by regulatory approvals that reinforce credibility. Together, they set a new benchmark for reproductive technology, likely prompting competitors to accelerate automation roadmaps and prompting investors to view fertility tech as a scalable, resilient segment within Indian healthcare.